Cardiovascular Research

Telomere Length and Magnetic Resonance Imaging Findings of Vascular Brain Injury and Central Brain Atrophy: The Strong Heart Stu

Authors: Astrid M Suchy-Dicey|||Clemma J Muller|||Tara M Madhyastha|||Dean Shibata|||Shelley A Cole|||Jinying Zhao|||W T Longstreth|||Dedra Buchwald

Affiliations: + Expand

Abstract

Telomeres are repeating regions of DNA that cap chromosomes. They shorten over the mammalian life span, especially in the presence of oxidative stress and inflammation. Telomeres may play a direct role in cell senescence, serving as markers of premature vascular aging. Leukocyte telomere length (LTL) may be associated with premature vascular brain injury and cerebral atrophy. However, reports have been inconsistent, especially among minority populations with a heavy burden of illness related to vascular aging. We examined associations between LTL and magnetic resonance imaging in 363 American Indians aged 64-93 years from the Strong Heart Study (1989-1991) and its ancillary study, Cerebrovascular Disease and Its Consequences in American Indians (2010-2013). Our results showed significant associations of LTL with ventricular enlargement and the presence of white matter hyperintensities. Secondary models indicated that renal function may mediate these associations, although small case numbers limited inference. Hypertension and diabetes showed little evidence of effect modification. Results were most extreme among participants who evinced the largest decline in LTL. Although this study was limited to cross-sectional comparisons, it represents (to our knowledge) the first consideration of associations between telomere length and brain aging in American Indians. Findings suggest a relationship between vascular aging by cell senescence and severity of brain disease.

---

Reference List

Aviv A. Leukocyte telomere length, hypertension, and atherosclerosis: are there potential mechanistic explanations? Hypertension. 2009;53(4):590–591.|||Eitan E, Hutchison ER, Mattson MP. Telomere shortening in neurological disorders: an abundance of unanswered questions. Trends Neurosci. 2014;37(5):256–263.|||Kappei D, Londono-Vallejo JA. Telomere length inheritance and aging. Mech Ageing Dev. 2008;129(1-2):17–26.|||Zhao J, Miao K, Wang H, et al. . Association between telomere length and type 2 diabetes mellitus: a meta-analysis. PLoS One. 2013;8(11):e79993.|||Fitzpatrick AL, Kronmal RA, Kimura M, et al. . Leukocyte telomere length and mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci. 2011;66(4):421–429.|||Hammadah M, Al Mheid I, Wilmot K, et al. . Telomere shortening, regenerative capacity, and cardiovascular outcomes. Circ Res. 2017;120(7):1130–1138.|||Peng H, Mete M, Desale S, et al. . Leukocyte telomere length and ideal cardiovascular health in American Indians: the Strong Heart Family Study. Eur J Epidemiol. 2017;32(1):67–75.|||Fitzpatrick AL, Kronmal RA, Gardner JP, et al. . Leukocyte telomere length and cardiovascular disease in the Cardiovascular Health Study. Am J Epidemiol. 2007;165(1):14–21.|||Ding H, Chen C, Shaffer JR, et al. . Telomere length and risk of stroke in Chinese. Stroke. 2012;43(3):658–663.|||Willeit P, Willeit J, Brandstätter A, et al. . Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler Thromb Vasc Biol. 2010;30(8):1649–1656.|||Zee RY, Castonguay AJ, Barton NS, et al. . Relative leukocyte telomere length and risk of incident ischemic stroke in men: a prospective, nested case-control approach. Rejuvenation Res. 2010;13(4):411–414.|||Fyhrquist F, Silventoinen K, Saijonmaa O, et al. . Telomere length and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE Study. J Hum Hypertens. 2011;25(12):711–718.|||Wikgren M, Karlsson T, Söderlund H, et al. . Shorter telomere length is linked to brain atrophy and white matter hyperintensities. Age Ageing. 2014;43(2):212–217.|||King KS, Kozlitina J, Rosenberg RN, et al. . Effect of leukocyte telomere length on total and regional brain volumes in a large population-based cohort. JAMA Neurol. 2014;71(10):1247–1254.|||Kota LN, Bharath S, Purushottam M, et al. . Reduced telomere length in neurodegenerative disorders may suggest shared biology. J Neuropsychiatry Clin Neurosci. 2015;27(2):e92–e96.|||Liu M, Huo YR, Wang J, et al. . Telomere shortening in Alzheimer’s disease patients. Ann Clin Lab Sci. 2016;46(3):260–265.|||Cai Z, Yan LJ, Ratka A. Telomere shortening and Alzheimer’s disease. Neuromolecular Med. 2013;15(1):25–48.|||Schürks M, Buring J, Dushkes R, et al. . Telomere length and Parkinson’s disease in men: a nested case-control study. Eur J Neurol. 2014;21(1):93–99.|||Endicott AA, Taylor JW, Walsh KM. Telomere length connects melanoma and glioma predispositions. Aging (Albany NY). 2016;8(3):423–424.|||Willeit P, Raschenberger J, Heydon EE, et al. . Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysis. PLoS One. 2014;9(11):e112483.|||Peng H, Zhu Y, Yeh F, et al. . Impact of biological aging on arterial aging in American Indians: findings from the Strong Heart Family Study. Aging (Albany NY). 2016;8(8):1583–1592.|||Haycock PC, Heydon EE, Kaptoge S, et al. . Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2014;349:g4227.|||Harwell TS, Oser CS, Okon NJ, et al. . Defining disparities in cardiovascular disease for American Indians: trends in heart disease and stroke mortality among American Indians and whites in Montana, 1991 to 2000. Circulation. 2005;112(15):2263–2267.|||Rosamond W, Flegal K, Friday G, et al. . Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115(5):e69–e171.|||Stansbury JP, Jia H, Williams LS, et al. . Ethnic disparities in stroke: epidemiology, acute care, and postacute outcomes. Stroke. 2005;36(2):374–386.|||Lee ET, Welty TK, Fabsitz R, et al. . The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol. 1990;132(6):1141–1155.|||Suchy-Dicey AM, Shibata D, Best LG, et al. . Cranial magnetic resonance imaging in elderly American Indians: design, methods, and implementation of the Cerebrovascular Disease and Its Consequences in American Indians Study. Neuroepidemiology. 2016;47(2):67–75.|||Suchy-Dicey AM, Shibata DK, Madhyastha TM, et al. . Findings of vascular brain injury and structural loss from cranial magnetic resonance imaging in elderly American Indians: the Strong Heart Study. Neuroepidemiology. 2017;48(1–2):39–47.|||Zhao J, Zhu Y, Lin J, et al. . Short leukocyte telomere length predicts risk of diabetes in American Indians: the Strong Heart Family Study. Diabetes. 2014;63(1):354–362.|||Inker LA, Shaffi K, Levey AS. Estimating glomerular filtration rate using the chronic kidney disease-epidemiology collaboration creatinine equation: better risk predictions. Circ Heart Fail. 2012;5(3):303–306.|||Inker LA, Schmid CH, Tighiouart H, et al. . Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–29.|||Zhu Y, Voruganti VS, Lin J, et al. . QTL mapping of leukocyte telomere length in American Indians: the Strong Heart Family Study. Aging (Albany NY). 2013;5(9):704–716.